Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

100 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mezigdomide combined with bortezomib disrupts the cell cycle and elicits superior antitumor effects in multiple myeloma.
Bjorklund CC, Larrayoz M, Kang J, Chiu H, Shtraizent N, Wu L, Li S, Hsu CC, Zhao J, Amatangelo M, Chow TT, Wollerman K, Singh RK, Sridhara S, Dudhgaonkar S, Subramanyam P, Ghosh K, Richardson PG, Bahlis NJ, Thakurta A, Martinez-Climent JA, Gandhi AK, Hagner PR. Bjorklund CC, et al. Among authors: larrayoz m. Blood Neoplasia. 2025 Nov 7;3(1):100179. doi: 10.1016/j.bneo.2025.100179. eCollection 2026 Feb. Blood Neoplasia. 2025. PMID: 41626055 Free PMC article.
Exploring the synergy between telomere length and genomic complexity in CLL.
Ramos-Campoy S, Puiggros A, Kamaso J, Parker H, Rigolin GM, Haferlach C, Larráyoz MJ, Collado R, Salgado R, Calasanz MJ, Etter L, Valiente A, Abrisqueta P, Bosch F, Gimeno E, Cuneo A, Nguyen-Khac F, Schoumans J, Strefford JC, Espinet B. Ramos-Campoy S, et al. Among authors: larrayoz mj. Br J Haematol. 2026 Jan 23. doi: 10.1111/bjh.70317. Online ahead of print. Br J Haematol. 2026. PMID: 41574981 No abstract available.
Interlaboratory cross validation of acute myeloid leukemia fusion genes and mutational targets detected by PCR: Performance of PETHEMA central laboratories.
Coucelo M, Sargas C, Ayala R, Larráyoz MJ, Chillón MC, Soria E, Bilbao C, de la Torre EP, Amorim ML, Mirales A, Cionfrini A, Simões AT, Oliveira AC, Rodríguez-Veiga R, Lloret-Madrid P, Mendizábal Y, Botella C, Bernal T, Bergua J, Algarra L, Tormo M, Sarmento-Ribeiro AB, Trigo F, Cortesão E, Martínez-Sánchez P, Serrano J, Alonso-Domínguez JM, García R, Amigo ML, Herrera-Puente P, Sayas MJ, Abuín A, Martínez-López J, Calasanz MJ, García-Sanz R, Gutiérrez N, Pérez-Simón JA, Gómez Casares MT, Sánchez-Garcia J, Montesinos P, Barragán E; PETHEMA group. Coucelo M, et al. Among authors: larrayoz mj. Leuk Res. 2026 Jan;160:108149. doi: 10.1016/j.leukres.2025.108149. Epub 2025 Dec 19. Leuk Res. 2026. PMID: 41443144
Selective depletion of B-cell subsets underlies increased risk of infection in MM patients treated with anti-BCMA vs -GPRC5D bsAbs.
Jelinek T, Žihala D, Zabaleta A, Kostopoulos IV, Soucek O, Venglar O, Moreno C, Fotiou D, Radova E, Tamariz-Amador LE, Theodorakakou F, Muronova L, Manubens A, Tsitsilonis O, Popková T, Gonzalez C, Anilkumar Sithara A, Corrado F, Bidikian N, Guerrero C, Kapustova V, Bilek D, Hagner PR, Larrayoz M, Martínez-Climent JA, Broskevičová L, Mihalyova J, Merz M, Sevcikova T, Ghobrial IM, San-Miguel JF, Dimopoulos MA, Rodriguez-Otero P, Radocha J, Kastritis E, Paiva B, Hajek R. Jelinek T, et al. Among authors: larrayoz m. Blood. 2025 Dec 17:blood.2025029572. doi: 10.1182/blood.2025029572. Online ahead of print. Blood. 2025. PMID: 41405507
Characterization of the bone marrow architecture of multiple myeloma using spatial transcriptomics.
Muiños-Lopez E, Lopez-Perez AR, Sudupe L, Vilas-Zornoza A, Sarvide S, Ripalda-Cemborain P, Aguirre-Ruiz P, Martin-Uriz PS, Larrayoz M, Alvarez-Gigli L, Abengozar-Muela M, Cenzano I, Cócera M, Ruiz J, Sancho I, Bantan A, Kurowska A, Ye J, Newton PT, Paiva B, Tamariz-Amador LE, Rodriguez-Madoz JR, Lagani V, Tegner J, Saez B, Martinez-Climent JA, Calvo IA, Gomez-Cabrero D, Prosper F. Muiños-Lopez E, et al. Among authors: larrayoz m. Commun Biol. 2025 Nov 20;8(1):1620. doi: 10.1038/s42003-025-08975-z. Commun Biol. 2025. PMID: 41266582 Free PMC article.
Reprogramming glutamine metabolism enhances BCMA-CAR T-cell fitness and therapeutic efficacy in multiple myeloma.
Navarro F, Lozano T, Fuentes-García A, Sánchez-Moreno I, Larrayoz M, Justicia P, Perucha B, Martinez-Tabar M, Martinez-Turrillas R, Casares N, Martín-Otal C, Gorraiz M, Meermeier EW, Chesi M, Lake D, Bergsagel PL, Santamaría E, Calleja-Cervantes ME, San Martín-Uriz P, Jordana-Urriza L, Agirre X, Hervás-Stubbs S, Rodriguez-Madoz JR, Martinez-Climent JÁ, Prosper F, Lasarte JJ. Navarro F, et al. Among authors: larrayoz m. Blood. 2025 Dec 11;146(24):2931-2944. doi: 10.1182/blood.2024027496. Blood. 2025. PMID: 40971494 Free PMC article.
SOX4 in chronic lymphocytic leukaemia: the forgotten transcription factor.
García-Muñoz R, Alberdi-Ballina J, Farfan-Quiroga G, Robles EF, Larráyoz MJ, Calasanz MJ, Martínez-Climent JÁ, Panizo C, Larreina-Pérez J, Rincón-López S, Atencio-Matos J, Campeny-Najara A, Esteban-Figuerola A, Hernandez-Perez M, Garrastachu-Zumaran P, Velasco-Ruiz M, de Gaona ER, Feliu J. García-Muñoz R, et al. Among authors: larrayoz mj. Blood Res. 2025 Jul 4;60(1):38. doi: 10.1007/s44313-025-00086-2. Blood Res. 2025. PMID: 40613823 Free PMC article.
From Sanger to Oxford Nanopore MinION Technology: The Impact of Third-Generation Sequencing on Genetic Hematological Diagnosis.
Larráyoz MJ, Luri-Martin P, Mañu A, Churruca O, Gordillo N, Erdozain I, Esteban-Figuerola A, de Miguel C, Robles D, García-Fortes M, Rifón Roca J, Alfonso-Pierola A, Prósper F, Ariceta B, Calasanz MJ. Larráyoz MJ, et al. Cancers (Basel). 2025 May 29;17(11):1811. doi: 10.3390/cancers17111811. Cancers (Basel). 2025. PMID: 40507293 Free PMC article.
Data-driven flow cytometry classification of blast differentiation in older patients with acute myeloid leukemia.
Simoes C, Gonzalez C, Vergez F, Sarry A, Bertoli S, Ariceta B, Martínez-Cuadrón D, Bergua JM, Vives S, Algarra L, Tormo M, Martinez P, Serrano J, Herrera P, Ramos F, Salamero O, Lavilla E, Gil C, Lopez-Lorenzo JL, Vidriales MB, Chillon C, Labrador J, Falantes JF, Sayas MJ, Ayala R, Martinez-Lopez J, Villar S, Calasanz MJ, Prosper F, San-Miguel JF, Sanz MÁ, Récher C, Paiva B, Montesinos P; PETHEMA Cooperative Study Group. Simoes C, et al. Blood Neoplasia. 2024 Jun 19;1(3):100027. doi: 10.1016/j.bneo.2024.100027. eCollection 2024 Sep. Blood Neoplasia. 2024. PMID: 40453058 Free PMC article. No abstract available.
ATM aberrations in chronic lymphocytic leukemia: del(11q) rather than ATM mutations is an adverse-prognostic biomarker.
Thorvaldsdottir B, Mansouri L, Sutton LA, Nadeu F, Meggendorfer M, Parker H, Brieghel C, Laidou S, Moia R, Rossi D, Kotaskova J, Delgado J, Rodríguez-Vicente AE, Benito R, Rigolin GM, Bonfiglio S, Scarfò L, Mattsson M, Davis Z, Baliakas P, Rapado I, Miras F, Martinez-Lopez J, de la Serna J, Hernández Rivas JM, Larráyoz MJ, Calasanz MJ, Smedby KE, Espinet B, Puiggros A, Bullinger L, Bosch F, Tazón-Vega B, Baran-Marszak F, Oscier D, Nguyen-Khac F, Zenz T, Terol MJ, Cuneo A, Hernández-Sánchez M, Pospisilova S, Gaidano G, Niemann CU, Campo E, Strefford JC, Ghia P, Stamatopoulos K, Rosenquist R. Thorvaldsdottir B, et al. Among authors: larrayoz mj. Leukemia. 2025 Jul;39(7):1650-1660. doi: 10.1038/s41375-025-02615-5. Epub 2025 Apr 24. Leukemia. 2025. PMID: 40275070 Free PMC article.
100 results